Literature DB >> 21336134

Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support.

Mariana Mirabel1, Charles-Edouard Luyt, Pascal Leprince, Jean-Louis Trouillet, Philippe Léger, Alain Pavie, Jean Chastre, Alain Combes.   

Abstract

OBJECTIVE: Myocarditis is a rare disease that may progress rapidly to refractory cardiogenic shock and death. In such situations, emergent initiation of mechanical circulatory assistance is the only therapeutic option to rescue these dying patients. This study was designed to evaluate the outcomes, health-related quality of life and frequencies of anxiety, depression and posttraumatic stress disorder symptoms in fulminant myocarditis patients rescued by mechanical circulatory assistance, since these major components of outcome evaluation after serious illnesses have not yet been assessed in this setting.
DESIGN: A retrospective, single-center, observational study and a cross-sectional survey to assess health-related quality of life by the Short Form-36 questionnaire and frequencies of anxiety, depression and posttraumatic stress disorder symptoms by the Hospital Anxiety and Depression Scale and the Impact of Event Scale, respectively.
SETTING: An 18-bed tertiary intensive care unit in a university hospital. PATIENTS: We analyzed the short- and long-term outcomes of 41 patients hospitalized at our institution between 2003 and 2009 and who received either a Thoratec BiVAD (Thoratec, Pleasanton, CA) (n = 6) or extracorporeal membrane oxygenation (n = 35) to combat refractory cardiogenic shock due to fulminant myocarditis.
MEASUREMENTS AND MAIN RESULTS: Intensive care unit survival was 68%, and four (10%) patients underwent heart transplantation. Independent predictors of in-intensive care unit death were Simplified Acute Physiology Score II ≥56 (odds ratio = 10.23) and troponin Ic ≥12 μg/L (odds ratio = 7.49) at admission. Complete follow-up (median, 525 days) was available for 26 of 28 survivors. Compared to age- and sex-matched controls, Short Form-36 evaluation of health-related quality of life revealed satisfactory mental health and vitality but persistent physical and psychosocial-related difficulties. Lastly, anxiety, depression, and/or posttraumatic stress disorder symptoms were reported by 38%, 27% and 27% of the patients, respectively.
CONCLUSIONS: Mechanical circulatory assistance rescued 68% of patients with refractory circulatory failure due to fulminant myocarditis. Greater disease severity and higher troponin Ic levels at extracorporeal membrane oxygenation initiation predicted poorer prognosis. Because up to one-third of the patients reported anxiety, depression, and/or posttraumatic stress disorder symptoms, strategies aimed at attenuating their emotional and psychologic distress might significantly improve their long-lasting well-being.

Entities:  

Mesh:

Year:  2011        PMID: 21336134     DOI: 10.1097/CCM.0b013e31820ead45

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  51 in total

Review 1.  What's new in myocarditis?

Authors:  Charles-Edouard Luyt; Guillaume Hékimian; Fredric Ginsberg
Journal:  Intensive Care Med       Date:  2015-08-14       Impact factor: 17.440

Review 2.  The ICM research agenda on extracorporeal life support.

Authors:  Alain Combes; Dan Brodie; Yih-Sharng Chen; Eddy Fan; José P S Henriques; Carol Hodgson; Philipp M Lepper; Pascal Leprince; Kunihiko Maekawa; Thomas Muller; Sebastian Nuding; Dagmar M Ouweneel; Antoine Roch; Matthieu Schmidt; Hiroo Takayama; Alain Vuylsteke; Karl Werdan; Laurent Papazian
Journal:  Intensive Care Med       Date:  2017-05-03       Impact factor: 17.440

Review 3.  Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients.

Authors:  Matteo Pozzi; Carlo Banfi; Daniel Grinberg; Catherine Koffel; Karim Bendjelid; Jacques Robin; Raphaël Giraud; Jean François Obadia
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  What's new in extracorporeal membrane oxygenation for cardiac failure and cardiac arrest in adults?

Authors:  Darryl Abrams; Alain Combes; Daniel Brodie
Journal:  Intensive Care Med       Date:  2014-01-29       Impact factor: 17.440

5.  Cardiovascular issues in the ICU: a call for papers.

Authors:  Antoine Vieillard-Baron; Anders Aneman
Journal:  Intensive Care Med       Date:  2017-09-25       Impact factor: 17.440

6.  Diagnosis, medical treatment, and stepwise mechanical circulatory support for fulminat myocarditis.

Authors:  Shunsuke Saito; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Hiroki Hata; Daisuke Yoshioka; Keitaro Domae; Yasumasa Tsukamoto; Yasushi Sakata; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2017-12-13       Impact factor: 1.731

7.  Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation.

Authors:  Matthieu Schmidt; Nicolas Bréchot; Sarah Hariri; Marguerite Guiguet; Charles Edouard Luyt; Ralouka Makri; Pascal Leprince; Jean-Louis Trouillet; Alain Pavie; Jean Chastre; Alain Combes
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

8.  Acute mechanical circulatory support for fulminant myocarditis complicated by cardiogenic shock.

Authors:  Kanika P Mody; Hiroo Takayama; Elissa Landes; Melana Yuzefpolskaya; Paolo C Colombo; Yoshifumi Naka; Ulrich P Jorde; Nir Uriel
Journal:  J Cardiovasc Transl Res       Date:  2014-01-14       Impact factor: 4.132

9.  Monitoring Cardiac Output and Transesophageal Echocardiography during Removal of a Ventricular Assist Device.

Authors:  Aslı Demir; Ümit Karadeniz; Bahar Aydınlı; Murat Taş; Özcan Erdemli
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-05-23

10.  Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.

Authors:  Marc Pineton de Chambrun; Nicolas Bréchot; Guillaume Lebreton; Matthieu Schmidt; Guillaume Hekimian; Pierre Demondion; Jean-Louis Trouillet; Pascal Leprince; Jean Chastre; Alain Combes; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2016-09-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.